Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13044 | 864 | 48.4 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
80 | 3 | DENTISTRY, ORAL SURGERY & MEDICINE//DENT//JOURNAL OF ENDODONTICS | 79662 |
256 | 2 | PLATELET RICH PLASMA//BONE REGENERATION//GUIDED TISSUE REGENERATION | 19657 |
13044 | 1 | GENE ACTIVATED MATRIX//SKELETAL BIOTECH//SOLID PHASE DELIVERY | 864 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GENE ACTIVATED MATRIX | authKW | 444051 | 2% | 74% | 17 |
2 | SKELETAL BIOTECH | address | 389608 | 2% | 53% | 21 |
3 | SOLID PHASE DELIVERY | authKW | 141362 | 0% | 100% | 4 |
4 | SUBSTRATE MEDIATED DELIVERY | authKW | 141358 | 1% | 67% | 6 |
5 | SKELETAL BIOTECHNOL | address | 125755 | 1% | 32% | 11 |
6 | GENE ACTIVATED MATRICES | authKW | 106021 | 0% | 100% | 3 |
7 | PROTECTIVE COPOLYMER | authKW | 106021 | 0% | 100% | 3 |
8 | BONE MORPHOGENETIC PROTEIN | authKW | 93077 | 9% | 4% | 74 |
9 | GENE THERAPY | authKW | 83893 | 21% | 1% | 185 |
10 | CATIONIZED GELATIN HYDROGEL | authKW | 79514 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell & Tissue Engineering | 11234 | 11% | 0% | 92 |
2 | Materials Science, Biomaterials | 9418 | 17% | 0% | 150 |
3 | Engineering, Biomedical | 5747 | 21% | 0% | 179 |
4 | Biotechnology & Applied Microbiology | 2953 | 25% | 0% | 220 |
5 | Medicine, Research & Experimental | 2898 | 22% | 0% | 192 |
6 | Genetics & Heredity | 1096 | 16% | 0% | 137 |
7 | Orthopedics | 794 | 9% | 0% | 75 |
8 | Cell Biology | 388 | 13% | 0% | 109 |
9 | Dentistry, Oral Surgery & Medicine | 138 | 4% | 0% | 32 |
10 | Pharmacology & Pharmacy | 134 | 10% | 0% | 85 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SKELETAL BIOTECH | 389608 | 2% | 53% | 21 |
2 | SKELETAL BIOTECHNOL | 125755 | 1% | 32% | 11 |
3 | BIONANOTECHNOL ADV MED | 70677 | 0% | 50% | 4 |
4 | MOL ORTHOPAED | 60922 | 2% | 13% | 13 |
5 | GEORGIA TECH EMORY ENGN LIVING TISSUES | 49465 | 1% | 20% | 7 |
6 | INTERDEPARTMENTAL BIOL SCI | 47119 | 0% | 67% | 2 |
7 | HADASSAH MED GENE THER Y | 45434 | 0% | 43% | 3 |
8 | INTER BIOL SCI | 43490 | 0% | 31% | 4 |
9 | CS RMI | 39754 | 0% | 38% | 3 |
10 | MICROBIOL IMMUNOL MOL GENET MED | 39754 | 0% | 38% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR THERAPY | 15125 | 5% | 1% | 39 |
2 | GENE THERAPY | 14405 | 5% | 1% | 40 |
3 | TISSUE ENGINEERING | 11179 | 2% | 2% | 21 |
4 | BIOMATERIALS | 10243 | 8% | 0% | 66 |
5 | JOURNAL OF GENE MEDICINE | 9049 | 2% | 1% | 19 |
6 | EUROPEAN CELLS & MATERIALS | 7581 | 1% | 2% | 10 |
7 | HUMAN GENE THERAPY | 5098 | 3% | 1% | 22 |
8 | JOURNAL OF CONTROLLED RELEASE | 3689 | 3% | 0% | 28 |
9 | CURRENT GENE THERAPY | 3146 | 1% | 1% | 7 |
10 | JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE | 2853 | 1% | 1% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BLEICH, NK , KALLAI, I , LIEBERMAN, JR , SCHWARZ, EM , PELLED, G , GAZIT, D , (2012) GENE THERAPY APPROACHES TO REGENERATING BONE.ADVANCED DRUG DELIVERY REVIEWS. VOL. 64. ISSUE 12. P. 1320 -1330 | 70 | 62% | 22 |
2 | EVANS, CH , (2012) GENE DELIVERY TO BONE.ADVANCED DRUG DELIVERY REVIEWS. VOL. 64. ISSUE 12. P. 1331 -1340 | 66 | 48% | 33 |
3 | LU, CH , CHANG, YH , LIN, SY , LI, KC , HU, YC , (2013) RECENT PROGRESSES IN GENE DELIVERY-BASED BONE TISSUE ENGINEERING.BIOTECHNOLOGY ADVANCES. VOL. 31. ISSUE 8. P. 1695-1706 | 71 | 42% | 27 |
4 | EVANS, CH , (2010) GENE THERAPY FOR BONE HEALING.EXPERT REVIEWS IN MOLECULAR MEDICINE. VOL. 12. ISSUE . P. - | 57 | 55% | 29 |
5 | TARASSOLI, P , KHAN, WS , HUGHES, A , HEIDARI, N , (2013) A REVIEW OF TECHNIQUES FOR GENE THERAPY IN BONE HEALING.CURRENT STEM CELL RESEARCH & THERAPY. VOL. 8. ISSUE 3. P. 201 -209 | 52 | 56% | 5 |
6 | EVANS, C , (2011) GENE THERAPY FOR THE REGENERATION OF BONE.INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. VOL. 42. ISSUE 6. P. 599 -604 | 43 | 62% | 29 |
7 | ROSE, L , ULUDAG, H , (2013) REALIZING THE POTENTIAL OF GENE-BASED MOLECULAR THERAPIES IN BONE REPAIR.JOURNAL OF BONE AND MINERAL RESEARCH. VOL. 28. ISSUE 11. P. 2245-2262 | 62 | 40% | 5 |
8 | IM, GI , (2013) NONVIRAL GENE TRANSFER STRATEGIES TO PROMOTE BONE REGENERATION.JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A. VOL. 101. ISSUE 10. P. 3009-3018 | 51 | 44% | 2 |
9 | ISHIHARA, A , BERTONE, AL , (2012) CELL-MEDIATED AND DIRECT GENE THERAPY FOR BONE REGENERATION.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 12. ISSUE 4. P. 411 -423 | 43 | 46% | 8 |
10 | CAROFINO, BC , LIEBERMAN, JR , (2008) GENE THERAPY APPLICATIONS FOR FRACTURE-HEALING.JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME. VOL. 90A. ISSUE . P. 99-110 | 42 | 49% | 25 |
Classes with closest relation at Level 1 |